SCHEMBL4193372

SCHEMBL4193372

CC(=COc1ccc2ccccc2c1)C(=O)OCCCOc1ccc(OCCCOC(=O)C(C)=COc2ccc3ccccc3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.46
PPARG P37231 4/20 0.45
PPARD Q03181 3/20 0.45
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 1/20 0.44
HDAC1 Q13547 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
PTPN7 P35236 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPK1 P28482 1/20 0.41
MTNR1A P48039 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4198432 0.96 PPARA (0.43) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4190462 0.94 KDM4E (0.44) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4204704 0.93 KDM4E (0.40) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4196022 0.89 KDM4E (0.38) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4198178 0.89 FFAR4 (0.42) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4198605 0.87 KDM4E (0.36) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4190895 0.85 MEN1 (0.44) KDM4EALDH1A1MAPK1NPC1MAPT
SCHEMBL4188687 0.84 FFAR4 (0.50) PPARAPPARGPPARDHDAC1HDAC3
SCHEMBL12851507 0.84 GAA (0.44) PPARAPPARGKDM4EPTPN7MAPT
SCHEMBL4197206 0.83 HDAC1 (0.46) PPARAPPARGPPARDHDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 PPARA 3322/4885PPARG 3465/4885PPARD 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.